Jaguar Health (JAGX) Return on Equity (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Return on Equity data on file, last reported at 0.02% in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.02%, up 13.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.02% (up 13.0% YoY), and the FY2025 annual result was 0.09%, up 16.0% from the prior year.
• Return on Equity slipped to 0.02% in Q1 2026 per JAGX's latest filing, from 0.08% in the prior quarter.
• Over five years, Return on Equity peaked at 0.08% in Q4 2025 and troughed at 0.43% in Q4 2022.
• A 5-year average of 0.09% and a median of 0.07% in 2025 frame the typical range for Return on Equity.
• The sharpest annual moves came in 2022 and 2023: Return on Equity tumbled 40 bps in 2022, then gained 30 bps in 2023.
• A 5-year view of Return on Equity shows it stood at 0.43% in 2022, then surged by 69 bps to 0.13% in 2023, then surged by 70 bps to 0.04% in 2024, then jumped by 288 bps to 0.08% in 2025, then plunged by 73 bps to 0.02% in 2026.
• Business Quant data shows JAGX's Return on Equity at 0.02% in Q1 2026, 0.08% in Q4 2025, and 0.07% in Q3 2025.